Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
Status:
Unknown status
Trial end date:
2020-06-17
Target enrollment:
Participant gender:
Summary
This pilot randomized controlled trial aims to evaluate the feasibility for safety
examination of continued metformin therapy in patients with type 2 diabetes (T2D) following
invasive coronary angiography. Metformin will be continued until coronary angiography.